Posted by Cosmetic Surgery Review on May 14, 2010
Artefill injectable fillers, one of the most sought-after procedures in the United States and among the highest-rated for patient satisfaction, was recently featured on the CBS medical talk show, “The Doctors”. The filler was part of a segment about “new body breakthroughs”, and showcased the injectable’s effectiveness for reducing the appearance of nasolabial folds – otherwise known as smile wrinkles.
Artefill is the first and only FDA-approved microsphere-enhanced dermal filler that can fill out nasolabial folds, and also promotes collagen production so that skin appears smoother, tighter and more toned. The filler was introduced in the United States in 2006 and has been administered to over 20,000 patients to date.
Since Artefill’s compounds are not readily absorbed by the body, the filler provides long-lasting, natural looking results and does not demand frequent touch up treatments.
Dr. Gilbert Lee, a board-certified plastic surgeon from San Diego, administered the Artefill injectable on a patient on the show. The patient was interested in freshening up her appearance before her wedding day, and the filler was injected directly into her smile lines. The audience and viewers could see immediate results.
Dr. Lee states, ‘I was an early adopter of Artefill and have been a big fan of the results that it delivers. It is a perfect solution for patients like Laura who want to enhance their appearance without looking like they’ve had work done. The results are immediate and last longer than any other dermal filler on the market today.
The procedure takes about fifteen minutes and already contains anesthetic, so there it is a virtually painless procedure. Some patients may experience slight redness and soreness in the treatment area, but this typically resolves itself within a few hours. Patients can resume regular activities, including eating and drinking, shortly after their procedure.
Posted in Artefill | Tagged: Artefill, artefill benefits, dermal fillers, injectable fillers | 4 Comments »
Posted by Cosmetic Surgery Review on March 15, 2010
Demand for minimally invasive procedures including Botox, Restylane and other injectable fillers continues to be strong in the United States and abroad, even more so in the wake of the economic recession.
Soft tissue injectables are not only effective for getting rid of wrinkles, reducing the appearance of fine lines and plumping up the skin, but can also help to improve the appearance of aging and sun-damaged skin by making the skin appear more resilient and smooth.
At this year’s American Academy of Dermatology Meeting, dermatologist Dana L. Sachs, MD, FAAD, associate professor in the department of dermatology at the University of Michigan in Ann Arbor, Michigan presented findings of a study that demonstrated how certain types of hyaluronic acid dermal fillers can stimulate collagen production and help to repair the skin. These may be some of the known side effects of certain fillers, and can help some patients achieve a more youthful look after a single treatment.
Structural damage to the skin is one of the most significant effects of the aging process, and the breakdown of collagen and elastin only increases at a steady rate as the individual ages. The common effects of aging include fine lines, skin laxity and pigmentation. Advanced stages of photoaging result in coarse wrinkles, redness and discoloration of sun-exposed skin. Some types of tissue fillers may be effective at changing the skin’s structure, reducing the effects of fragmentation and helping the tissues regenerate higher levels of collagen which creates a smooth and healthy appearance.
Dr. Sachs reports, “from a clinical standpoint, dermatologists know that soft tissue fillers work by restoring volume loss and smoothing wrinkles in aging and sun-damaged skin…the biochemical study of cross-linked hyaluronic acid conducted by researchers set out to explain what takes place at the molecular level to account for the observed clinical improvements.” (Source: Medical News Today)
Posted in Antiaging, wrinkle treatments | Tagged: collagen fillers, dermal fillers, injectable fillers, injectables | 1 Comment »
Posted by Cosmetic Surgery Review on March 2, 2010
Artefill is among the leading dermal fillers on the market to treat lines and wrinkles, and is currently available at many medical spas, cosmetic surgery centers and plastic surgery centers around the country.
The injectable was recently part of two clinical studies to determine if it would be effective as a long-term treatment for facial lipoatrophy. Results of the study were presented at the Advances in Cosmetic and Medical Dermatology’s Maui Derm 2010” meeting in Hawaii in late January, and at the American Academy of Cosmetic Dermatology Scientific Meeting in Orlando, Florida later that month.
The soft tissue filler is currently used to treat nasolabial folds, reduce lines and wrinkles around the cheeks and forehead, and can be part of a “liquid facelift” procedure. The study evaluated the efficacy of Artefill for thecorrection of lipoatrophy in HIV patients. Patients received injections over a six-month period until full correction was achieved, and were monitored shortly after the injection was administered to determine if any muscle atrophy occurred.
According to Dr. Joseph Eviatar, FACS of Chelsea Eye and Cosmetic Surgery Associates who presented at the AACS Scientific Meeting, “Artefill proved to be effective in restoring volume to the face in these HIV lipoatrophy patients and we believe may offer a more long-term, cost effective treatment option for the patient population.”
In another session presented at the Maui Derm 2010 conference, doctors reported that Artefill was effective in treating all HIV lipoatrophy patients and improvement ranged between 50 to 100 percent. Non-HIV patients also experienced a significant improvement in the overall contours of the face.
Dr. Farhad Niroomand, Associate Clinical Professor of Dermatology who presented at the Maui conference, also stated that he believes Artefill is a viable treatment option for non-surgical anti-aging enhancement, and is a viable treatment option for patients with lipoatrophy. (Source: MedicalNewsToday.com)
Posted in Artefill | Tagged: Artefill, dermal fillers, facial treatments, injectables | Leave a Comment »
Posted by Cosmetic Surgery Review on February 24, 2010
Juvederm is one of the most popular dermal fillers available at medical spas and cosmetic surgery centers around the country.
The hyaluronic acid filler is administered to reduce the appearance of fine lines and wrinkles, and is especially effective for treating nasolabial folds around the nose and mouth area. Now, the injectable has been formulated with lidocaine to ward off pain and increase the patient’s level of comfort.
The U.S. Food and Drug Administration has approved the dermal filler with lidocaine for use n the consumer market, making Juvederm the first and only dermal filler to have received FDA approval for up to one year from initial treatment.
According to Robert Grant, Corporate Vice President of Allergan and President of Allergan Medical, “We lead innovation in the dermal filler category with the first and only smooth-consistency gel hyaluronic acid dermal filler approved by the FDA to last up to a year. Now we have added lidocaine to Juvederm to provide the same smooth, long-lasting result, but with additional comfort for patients.”
Lidocaine helps to numb the treatment area within seconds of being injected into the skin, which means the administering physician or medical professional does not need to apply topical numbing agents to the area. Juvederm can be administered in several areas of the face at once, and produces instant results that can last for several months.
Before Juvederm was formulated with Lidocaine, it could take up to 30 minutes for the topical anesthetic to begin working, and many patients still tolerated a certain level of pain during and after the treatment. Lidocaine helps to minimize the effects of the acid going into the dermis, and also reduces pain from the injection’s needle.
Juvederm with lidocaine is now available nationwide, and is available only by a prescription by a certified medical practitioner.
Posted in Cosmetic Surgery News, dermal fillers | Tagged: anti-aging, Cosmetic Surgery News, dermal fillers, injectable fillers, Juvederm | Leave a Comment »
Posted by Cosmetic Surgery Review on February 1, 2010
Despite physicians warnings that self-injecting fillers such as Botox, Juvederm and Restylane can be dangerous, many people are still exploring the idea of purchasing fillers on their own and giving themselves an anti-aging quick fix from the comforts of home.
Plastic surgeons at Southwestern Medical Center warn that people looking to save money on their wrinkle treatments should not even consider sourcing and injecting prescription-strength fillers on their own. Vice Chairman of Plastic Surgery at UT Southwestern, Dr. Jeffrey Kenkel, states, “It’s critical to seek out a board-certified plastic surgeon or dermatologist to ensure that the material being injected is authentic, that the proper amount is being injected and that the fillers are injected in the proper location to avoid unwanted consequences.” (Source: UTSouthwestern.edu)
Complications and risks associated with self-injecting fillers can include anything from excessive swelling, migration of the compound to other areas of the face, scarring, infection and in some cases, bleeding. Individuals who inject fillers around the upper facial area and forehead may also experience droopy eyelids or excessive swelling that can become difficult to correct.
Still, even with the known risks, many people are turning to the Internet or finding a way to get injectable filler compounds so that they can perform these risky procedures themselves. Dr. Kenkel points out that there are many ways to improve the appearance safely and cost-effectively, and that self-injection presents far too many risks that outweigh the initial benefit.
While the average injectable costs between $300 to $500+ per treatment area, there are other options. Many patients can reduce the appearance of wrinkles with cosmetic treatments such as Thermage skin tightening procedures, laser skin resurfacing, microdermabrasion and chemical peels, and microcurrent facials. All of these procedures must be performed by a board-certified cosmetic surgeon or licensed medical professional, as these individuals will comply with safety standards and ensure the most favorable outcome is achieved for all patients.
Posted in Antiaging, Cosmetic Surgery News | Tagged: dermal filler, dermal fillers, injectable, injections | Leave a Comment »
Posted by Cosmetic Surgery Review on November 30, 2009
Mara Micevic of Oakville received Evolence injections in January 2007 from a local laser and spa clinic after the center promised she could improve her looks and achieve a more youthful appearance. Ms. Micevic states that “she didn’t think twice” about getting the injections because she had known many women who had gone to these types of clinics and had been able to improve their appearance.
However, Micevic reports that immediately after Evolence was injected into her lips, she could feel a set of “small balls” under her skin and was assured that they would disappear. Eight months later, she developed a bump under her top lip that began to ooze pus and blood. Soon after, her whole face was swollen and she got infections over her entire face.
Ms. Micevic contacted the manufacturer in 2008, she found out that Evolence was not indicated for use in the lips at all. However, the filler had been marketed as an all-natural filler for lip augmentation in the United States and in Canada, and was made available at several medical spas and cosmetic surgery centers around the country.
Evolence is among the newest dermal fillers on the market, an injectable that promises to fill out fine lines and wrinkles instantly and produces natural-looking results. It costs approximately $500 per injection, and according to the American Society of Plastic Surgeons, Americans are spending approximately $800 million per year on injectables.
Some injectables, such as collagen fillers, do have a high risk of allergies and doctors may need to do a test before administering the entire injectable.
For Micevic, the side effects were enough to prompt a lawsuit against Johnson & Johnson and related companies who are failing to warn the public about the risk of injury, scarring, infection and disfigurement from using Evolence. Two other women in Richmond, B.C. have also launched a notice to sue over Evolence in December 2008.
On November 3, 2009, Johnson & Johnson announced that it would discontinue the manufacture and marketing of Evolence products.
Posted in evolence, wrinkle treatments | Tagged: dermal fillers, evolence, evolence lawsuit, injectable fillers, injectables, wrinkle treatments | Leave a Comment »
Posted by Cosmetic Surgery Review on November 12, 2009
Millions of men and women seek wrinkle reduction with the use of dermal fillers or injectables, a set of injections that can make the skin appear smoother and more youthful immediately after treatment.
Fillers such as Restylane, Juvederm and Botox can decrease lines and wrinkles while smoothing out and sculpting the face. Now, researchers are finding that when the injections are mixed with a certain amount of lidocaine, the patient experiences less swelling and pain from the procedure, and also spends less time in the office waiting for the anesthesia to take effect.
Plastic surgeons at UT Southwestern medical Center have outlined this innovative technique in the October issue of Plastic and Reconstructive Surgery, indicating that lidocaine in the fillers will instantly minimize pain and make it easier on the patient. The addition of lidocaine also means a shorter recovery time.
According to Dr. Rod Rohric, chairman of plastic surgery at UT Southwestern, the technique involves mixing 2 percent lidocaine with hyaluronic acid and other fillers to create a numbing effect while the injectable is administered into the skin. Dr. Rohric also points out that the addition of lidocaine is becoming more standard with the emergence of fillers such as Hydrelle and Prevelle which already have lidocaine in their list of ingredients.
Demand for minimally invasive procedures such as Restylane, Botox and Hydrelle continue to rise as more men and women seek alternatives to surgery in order to preserve their youthful appearance. Adding a certain concentration of lidocaine to the injectable may help the surgeon minimize the pain and swelling commonly associated with the procedure, and this may make the entire treatment more attractive to people who have refrained from undergoing the pain and discomfort associated with treatment.
More information about injectable fillers as an anti-aging treatment can be found here.
Posted in Antiaging, dermal fillers | Tagged: anti-aging, dermal fillers, injectable fillers, injectables | Leave a Comment »
Posted by Cosmetic Surgery Review on October 30, 2009
Today’s most popular dermal fillers include Restylane, Juvederm and Botox, and hyaluronic acid fillers ar frequently used to correct wrinkles and fine lines, reshape and contour the face, and to create a more youthful appearance. Researchers are now reviewing an innovative dermal filler called ATX-104.
Unlike regular injectables that are simply injected into the skin to produce immediate results, the ATX-104 works only after it comes into contact with an external light source. After it is injected, the filler is shaped and polymerized transdermally with the help of external light.
The ATX-104 filler is based on KYTHERA’s proprietary photochemistry platform and has been developed at Johns Hopkins University. Scientists are studying the effects of the light reaction, and working on ways to optimize the filler so that it can create dramatic results and be used to reshape the face.
Different types of injectable fillers can produce different results based on the strength of the filler, and the person’s existing skin conditions. Hyaluronic acid fillers such as Juvederm and Restylane are commonly used to reshape the face, fill out wrinkles and lines around the mouth and nose, and to correct sagging skin. Botox is most commonly used to correct deep wrinkles on the forehead, but also has other uses including treating headaches and migraines, or stopping sweating.
So far, the ATX-104 system has been able to produce better results than many of the fillers that are readily available. It is still undergoing testing, and Kythera Biopharmaceuticals has announced that the first in-human trial of the light-activated filler was successful.
Kythera Biopharmaceuticals is a biotechnology company based out of California, and was started by former employees of Amgen. It has about $40 million in funding, and is working on the ATX-104 system, along with three other products designed specifically for the aesthetic market.
Posted in Antiaging, dermal fillers | Tagged: anti aging news, anti-aging, dermal filler, dermal fillers, injectable fillers, light therapy | Leave a Comment »
Posted by Cosmetic Surgery Review on October 27, 2009
The results of a recent study investigating the injectable Aquamid were revealed at The American Society of Dermatologic Surgery (ASDS) 2009 meeting.
Aquamid is an injectable filler designed to treat fine lines and wrinkles, and is made with 2.5% polyacrylamide hydrogel and, according to the results of the study, is as well tolerated as hyaluronic acid fillers such as Restylane and Juvederm.
Rhoda Narins, MD, Clinical Professor of Dermatology of the New York University School of Medicine in New York City and Director of the Dermatology Surgery and Laser Center of New York reports that, “our results demonstrate that polyacrylamide hydrogel shows strong potential as a permanent soft tissue filler.” The ingredients in Aquamid are non-biodegradable, which means this particular filler cannot migrate. The compound is also expected to last longer than traditional hyaluronic fillers, which may be a cost benefit to consumers.
Aquamid is marketed as a soft volume filler to enhance facial contours, fill out nasolabial folds, smooth out wrinkles and folds in the cheeks and lips, and can also be used to reshape the nose. The filler boasts natural-looking results and lasting satisfaction. In long-term clinical trials, physicians judged the aesthetic results at one, two and four year intervals, and found that results were still good or very good for more than 90% of patients at each interval.
Data after five years shows that patients were either very satisfied or satisfied with results during the follow-up session, and the filler produced similar aesthetic results. The filler is designed to completely integrate with the body’s tissues, which means there is no risk of an allergic reaction to the micro-particles present in the compound. Aquamid is also not linked to tissue hardening or fibrosis.
Efficacy of Aquamid was maintained through the 12-month post follow up treatment for the filler, and showed a significant improvement in results in treatment groups.
Posted in Antiaging, wrinkle treatments | Tagged: anti-aging, aquamid, dermal fillers, injectable fillers, wrinkle treatments | Leave a Comment »
Posted by Cosmetic Surgery Review on September 24, 2009
The U.S. Food and Drug Administration is currently reviewing a new dermal filler product called Belotero Balance. If approved, this injectable will join the likes of Juvederm, Perlane, Restylane and Prevelle Silk as an anti-aging treatment for moderate to severe wrinkles.
Belotero Balance is manufactured by Merz Pharmaceuticals, and is a “hyaluronic acid based monophasic gel” that works in a similar way as Restylane and Juvederm Belotoro Balance is designed to treat moderate to severe wrinkles in the face and neck area, and was first launched in Germany in 2005.
The filler has already been approved for aesthetic use as a wrinkle filler in the United Kingdom, Austria, Russia, Italy and Switzerland. The injectable can be used on almost any area of the face, and is designed to smooth out deeper wrinkles and grooves, create more attractive facial contours, and create a more youthful look.
According to Jack Britts, president and CEO of Merz Pharmaceuticals, LLC, “The FDA’s acceptance for review of the Belotero Balance PMA begins the application review process and signifies the beginning of Merz Pharmaceutical’s firm footprint in the American aesthetics market.” (Source: Drugs.com)
Belotero Balance is another non-animal stabilized hyaluronic acid filler that may be administered on an outpatient basis. Still, there are many things we don’t know about Belotero Balance. There are currently no published reports on whether Belotero Balance lasts longer than filler such as Restylane and Juvederm, or whether it is valuable for using as part of a ‘liquid facelift’ treatment.
Since the majority of hyaluronic acid fillers boast little to no complications, Belotero Balance may similarly have a low risk of severe complications, and may also be offered at a more competitive price point – only time will tell, and the United States may need to wait several months until the FDA completes the initial review process.
Posted in Cosmetic Surgery, dermal fillers | Tagged: belotero, belotero fillers, Cosmetic Surgery News, dermal fillers, injectable | Leave a Comment »